Literature DB >> 10197603

Localization of PS6K to chromosomal region 17q23 and determination of its amplification in breast cancer.

F J Couch1, X Y Wang, G J Wu, J Qian, R B Jenkins, C D James.   

Abstract

The application of comparative genomic hybridization to the analysis of genetic abnormalities in breast carcinoma has consistently revealed that chromosome region 17q22-24 is a frequent site of gene amplification in this type of cancer. As part of an examination of expressed sequence tags for novel amplified genes in this region, we identified PS6K amplifications in both breast tumor tissues and cell lines. PS6K was localized to 17q23 and encodes a serine-threonine kinase whose activation is thought to regulate a wide array of cellular processes involved in the mitogenic response including protein synthesis, translation of specific mRNA species, and cell cycle progression from G1 to S phase. Northern and Western analyses revealed that amplification of this gene was accompanied by corresponding increases in mRNA and protein expression, respectively. These data represent the first determination of a gene amplification within 17q22-24 in breast cancer and suggest an oncogenic activity for PS6K.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10197603

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  29 in total

Review 1.  Methods of molecular analysis: assessing losses and gains in tumours.

Authors:  R Roylance
Journal:  Mol Pathol       Date:  2002-02

2.  Virtual genome scan: a tool for restriction landmark-based scanning of the human genome.

Authors:  J M Rouillard; A E Erson; R Kuick; J Asakawa ; K Wimmer; M Muleris; E M Petty; S Hanash
Journal:  Genome Res       Date:  2001-08       Impact factor: 9.043

Review 3.  Mammalian target of rapamycin: a central node of complex signaling cascades.

Authors:  Yoh Dobashi; Yasutaka Watanabe; Chihiro Miwa; Sakae Suzuki; Shinichiro Koyama
Journal:  Int J Clin Exp Pathol       Date:  2011-06-14

4.  Chromosome 2 (2p16) abnormalities in Carney complex tumours.

Authors:  L Matyakhina; S Pack; L S Kirschner; E Pak; P Mannan; J Jaikumar; S E Taymans; F Sandrini; J A Carney; C A Stratakis
Journal:  J Med Genet       Date:  2003-04       Impact factor: 6.318

5.  Detection of gene amplification in archival breast cancer specimens by laser-assisted microdissection and quantitative real-time polymerase chain reaction.

Authors:  U Lehmann; S Glöckner; W Kleeberger; H F von Wasielewski; H Kreipe
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

6.  USP32 is an active, membrane-bound ubiquitin protease overexpressed in breast cancers.

Authors:  Shiva Akhavantabasi; Hesna B Akman; Aysegul Sapmaz; Jennifer Keller; Elizabeth M Petty; Ayse E Erson
Journal:  Mamm Genome       Date:  2010-06-13       Impact factor: 2.957

7.  The role of S6K1 in ER-positive breast cancer.

Authors:  Marina K Holz
Journal:  Cell Cycle       Date:  2012-08-16       Impact factor: 4.534

8.  The Circadian Protein BMAL1 Regulates Translation in Response to S6K1-Mediated Phosphorylation.

Authors:  Jonathan O Lipton; Elizabeth D Yuan; Lara M Boyle; Darius Ebrahimi-Fakhari; Erica Kwiatkowski; Ashwin Nathan; Thomas Güttler; Fred Davis; John M Asara; Mustafa Sahin
Journal:  Cell       Date:  2015-05-14       Impact factor: 41.582

9.  mTOR/p70S6K signal transduction pathway contributes to osteosarcoma progression and patients' prognosis.

Authors:  Quan Zhou; Zhansheng Deng; Yong Zhu; Haitao Long; Shaoxian Zhang; Jiali Zhao
Journal:  Med Oncol       Date:  2009-11-20       Impact factor: 3.064

Review 10.  Role of mTOR in anticancer drug resistance: perspectives for improved drug treatment.

Authors:  Bing-Hua Jiang; Ling-Zhi Liu
Journal:  Drug Resist Updat       Date:  2008-04-28       Impact factor: 18.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.